MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 184 filers reported holding MYOKARDIA INC in Q4 2019. The put-call ratio across all filers is 1.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $15,936,000 | +120.5% | 116,890 | +56.3% | 0.02% | +120.0% |
| Q2 2020 | $7,226,000 | +146.3% | 74,790 | +19.5% | 0.01% | +100.0% |
| Q1 2020 | $2,934,000 | -39.5% | 62,586 | -6.0% | 0.01% | -28.6% |
| Q4 2019 | $4,853,000 | +39.8% | 66,586 | 0.0% | 0.01% | +40.0% |
| Q3 2019 | $3,472,000 | +8.9% | 66,586 | +4.7% | 0.01% | 0.0% |
| Q2 2019 | $3,188,000 | -2.8% | 63,582 | +0.8% | 0.01% | 0.0% |
| Q1 2019 | $3,280,000 | +49.2% | 63,082 | +40.2% | 0.01% | +25.0% |
| Q4 2018 | $2,199,000 | -27.0% | 44,997 | -2.6% | 0.00% | 0.0% |
| Q3 2018 | $3,012,000 | +59.2% | 46,197 | +21.3% | 0.00% | +33.3% |
| Q2 2018 | $1,892,000 | +25.0% | 38,097 | +22.9% | 0.00% | +50.0% |
| Q1 2018 | $1,513,000 | +106.1% | 31,000 | +77.9% | 0.00% | +100.0% |
| Q4 2017 | $734,000 | +101.6% | 17,429 | +105.0% | 0.00% | 0.0% |
| Q3 2017 | $364,000 | – | 8,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 399,360 | $38,586,000 | 34.31% |
| Copernicus Capital Management, LLC | 57,000 | $5,507,000 | 6.04% |
| Foresite Capital Management IV, LLC | 126,492 | $12,222,000 | 5.95% |
| Casdin Capital, LLC | 870,000 | $84,059,000 | 4.98% |
| Avoro Capital Advisors LLC | 1,880,000 | $181,646,000 | 3.59% |
| RTW INVESTMENTS, LP | 936,931 | $90,526,000 | 2.55% |
| Cormorant Asset Management, LP | 600,000 | $57,972,000 | 2.21% |
| Perceptive Advisors | 1,395,017 | $134,787,000 | 2.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 65,859 | $6,372,000 | 2.12% |
| Grace Capital | 24,400 | $2,358,000 | 2.02% |